Kyleena 19.5 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FGAU6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,909
Award facts
- Contract value 100% obligated
- $5,908.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $5,908.95 to DMS Pharmaceutical Group Inc. for Kyleena 19.5 mg contraceptive systems. The award, issued on January 22, 2026, with an ultimate completion date of February 12, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected to provide these medical devices to support Department of Defense healthcare operations. The delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) established through the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.
The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to establish regional prime vendor contractors capable of supplying comprehensive pharmaceutical and medical consumables to military healthcare facilities worldwide. DMS Pharmaceutical Group's IDC, awarded in November 2025 with a $499.999 billion ceiling and completion date of December 31, 2036, authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contractor's established performance on numerous prior delivery orders demonstrates its capacity to fulfill the diverse and specialized pharmaceutical requirements of the Department of Defense military medical system.
Quick answers
Who was awarded contract SPE2DR26FGAU6?
SPE2DR26FGAU6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FGAU6 worth?
The government has obligated $5,909 on SPE2DR26FGAU6.
Is contract SPE2DR26FGAU6 an order under another contract?
Yes. SPE2DR26FGAU6 is a delivery order under SPE2DR25D9371, an indefinite delivery contract.
Was contract SPE2DR26FGAU6 competed?
The extent of competition for SPE2DR26FGAU6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award